Rigel Pharmaceuticals, Inc. (RIGL)
36.96
-0.97
(-2.56%)
USD |
NASDAQ |
Jan 23, 16:00
37.21
+0.25
(+0.68%)
After-Hours: 20:00
Rigel Pharmaceuticals Research and Development Expense (TTM): 28.24M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Nektar Therapeutics | 116.36M |
| Ironwood Pharmaceuticals, Inc. | 95.29M |
| Catalyst Pharmaceuticals, Inc. | 14.70M |
| Perspective Therapeutics, Inc. | 61.22M |
| Vertex Pharmaceuticals, Inc. | 3.954B |